Compare MSTR & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSTR | BDX |
|---|---|---|
| Founded | 1989 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6B | 51.5B |
| IPO Year | 1998 | 1995 |
| Metric | MSTR | BDX |
|---|---|---|
| Price | $182.59 | $146.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $343.77 | $186.00 |
| AVG Volume (30 Days) | ★ 15.2M | 2.5M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | $463,456,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $5.22 | N/A |
| Revenue Next Year | $2.41 | $3.02 |
| P/E Ratio | ★ N/A | $109.50 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $105.00 | $144.51 |
| 52 Week High | $457.22 | $213.08 |
| Indicator | MSTR | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 33.04 |
| Support Level | $153.79 | N/A |
| Resistance Level | $186.73 | $159.79 |
| Average True Range (ATR) | 9.63 | 3.35 |
| MACD | 1.70 | -0.30 |
| Stochastic Oscillator | 92.84 | 15.77 |
Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software. It has one reportable operating segment: the Software Business, which is engaged in the design, development, marketing, and sales of the company's enterprise analytics software platform through cloud subscriptions and licensing arrangements and related services (i.e., product support, consulting, and education). Geographically, the company operates in EMEA, U.S. and Other Regions, of which maximum revenue is derived from U.S..
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.